Kosacz Barbara 4
4 · Athira Pharma, Inc. · Filed May 27, 2022
Insider Transaction Report
Form 4
Kosacz Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-20+13,871→ 13,871 totalExercise: $8.93Exp: 2032-05-19→ Common Stock (13,871 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) May 20, 2023, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 20, 2022. The option reported was granted pursuant to the terms of the Issuer's outside director compensation policy.